JPWO2020195437A1 - - Google Patents

Info

Publication number
JPWO2020195437A1
JPWO2020195437A1 JP2021508823A JP2021508823A JPWO2020195437A1 JP WO2020195437 A1 JPWO2020195437 A1 JP WO2020195437A1 JP 2021508823 A JP2021508823 A JP 2021508823A JP 2021508823 A JP2021508823 A JP 2021508823A JP WO2020195437 A1 JPWO2020195437 A1 JP WO2020195437A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021508823A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020195437A1 publication Critical patent/JPWO2020195437A1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00Other general methods
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
JP2021508823A 2019-03-27 2020-02-21 Pending JPWO2020195437A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019060295 2019-03-27
PCT/JP2020/007196 WO2020195437A1 (ja) 2019-03-27 2020-02-21 プロスタグランジンの製造方法

Publications (1)

Publication Number Publication Date
JPWO2020195437A1 true JPWO2020195437A1 (ja) 2020-10-01

Family

ID=72609003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021508823A Pending JPWO2020195437A1 (ja) 2019-03-27 2020-02-21

Country Status (7)

Country Link
US (1) US20220169600A1 (ja)
EP (1) EP3950672A4 (ja)
JP (1) JPWO2020195437A1 (ja)
KR (1) KR20210143744A (ja)
CN (1) CN113557227A (ja)
CA (1) CA3132572A1 (ja)
WO (1) WO2020195437A1 (ja)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10598A (en) 1854-03-07 Improvement in sash-su stain ers
US3726983A (en) 1971-05-14 1973-04-10 Alza Corp Pharmaceutical compositions comprising tetrahydropyran-2{40 -yl prostaglandin ethers
US6248783B1 (en) 2000-09-20 2001-06-19 Allergan Sales, Inc. Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US7511168B2 (en) 2006-01-18 2009-03-31 Shih-Yi Wei Processes and intermediates for the preparations of prostaglandins
CN103755737A (zh) 2006-02-07 2014-04-30 株式会社·R-技术上野 用于制备前列腺素衍生物的方法
JP2008037782A (ja) * 2006-08-04 2008-02-21 Daiichi Fine Chemical Co Ltd プロスタグランジン誘導体の製造方法
CN101555221B (zh) 2008-04-09 2013-01-23 明德国际仓储贸易(上海)有限公司 一种前列腺素f型衍生物的制造方法
WO2012011128A1 (en) * 2010-07-23 2012-01-26 Aptuit Laurus Private Limited Preparation of prostaglandin derivatives
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
WO2014200094A1 (ja) * 2013-06-14 2014-12-18 日産化学工業株式会社 光学活性アルコール化合物の製造方法
US9115109B2 (en) 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
JP6795974B2 (ja) * 2014-03-06 2020-12-02 日産化学株式会社 光学活性アゼチジノン化合物の製造方法
CN105985371B (zh) 2015-02-11 2019-06-18 常州博海威医药科技股份有限公司 制备利马前列腺素的关键中间体及其应用

Also Published As

Publication number Publication date
EP3950672A1 (en) 2022-02-09
CN113557227A (zh) 2021-10-26
TW202102472A (zh) 2021-01-16
EP3950672A4 (en) 2023-01-11
KR20210143744A (ko) 2021-11-29
US20220169600A1 (en) 2022-06-02
CA3132572A1 (en) 2020-10-01
WO2020195437A1 (ja) 2020-10-01

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021017339A2 (ja)
BR112021013854A2 (ja)
BR112021018450A2 (ja)
BR112021017939A2 (ja)
BR112021017892A2 (ja)
BR112019016141A2 (ja)
AU2020104490A4 (ja)
BR112021017738A2 (ja)
BR112021017782A2 (ja)
BR112019016142A2 (ja)
BR112019016138A2 (ja)
BR112021018168A2 (ja)
BR112021017728A2 (ja)
BR112021017234A2 (ja)
BR112021017355A2 (ja)
BR112021018102A2 (ja)
BR112021017173A2 (ja)
BR112021017083A2 (ja)
BR112021017637A2 (ja)
BR112021008711A2 (ja)
BR112021018452A2 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021018093A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240314